DNA hypermethylation in disease: mechanisms and clinical relevance

M Ehrlich - Epigenetics, 2019 - Taylor & Francis
Increasing numbers of studies implicate abnormal DNA methylation in cancer and many non-
malignant diseases. This is consistent with numerous findings about differentiation …

Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance

C Huang, P Azizi, M Vazirzadeh… - Journal of Translational …, 2023 - Springer
Cancer is a complex disease with many contributing factors, and researchers have gained
extensive knowledge that has helped them understand the diverse and varied nature of …

[HTML][HTML] Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer

E Donnarumma, D Fiore, M Nappa, G Roscigno… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cancer-associated fibroblasts (CAFs) are the major components of the tumor
microenvironment. They may drive tumor progression, although the mechanisms involved …

Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets

KMT Arif, EK Elliott, LM Haupt, LR Griffiths - Cancers, 2020 - mdpi.com
Simple Summary By the virtue of targeting multiple genes, a microRNA (miRNA) can infer
variable consequences on tumorigenesis by appearing as both a tumour suppressor and …

MicroRNAs contribute to breast cancer invasiveness

I Fridrichova, I Zmetakova - Cells, 2019 - mdpi.com
Cancer statistics in 2018 highlight an 8.6 million incidence in female cancers, and 4.2 million
cancer deaths globally. Moreover, breast cancer is the most frequent malignancy in females …

The role of exo-miRNAs in cancer: a focus on therapeutic and diagnostic applications

F Ingenito, G Roscigno, A Affinito, S Nuzzo… - International journal of …, 2019 - mdpi.com
Exosomes are extracellular vesicles released into biological fluids where they act as carriers
of various molecules, including proteins, lipids, and RNAs, between cells, modulating or …

A step-by-step microRNA guide to cancer development and metastasis

GS Markopoulos, E Roupakia, M Tokamani… - Cellular Oncology, 2017 - Springer
Background Cancer is one of the leading causes of mortality. The neoplastic transformation
of normal cells to cancer cells is caused by a progressive accumulation of genetic and …

The breast cancer stem cells traits and drug resistance

Q Zheng, M Zhang, F Zhou, L Zhang… - Frontiers in …, 2021 - frontiersin.org
Drug resistance is a major challenge in breast cancer (BC) treatment at present.
Accumulating studies indicate that breast cancer stem cells (BCSCs) are responsible for the …

The mechanism of DNA methylation and miRNA in breast cancer

L Ma, C Li, H Yin, J Huang, S Yu, J Zhao… - International Journal of …, 2023 - mdpi.com
Breast cancer is the most prevalent cancer in the world. Currently, the main treatments for
breast cancer are radiotherapy, chemotherapy, targeted therapy and surgery. The treatment …

[HTML][HTML] DNMT3A and DNMT3B in breast tumorigenesis and potential therapy

X Man, Q Li, B Wang, H Zhang, S Zhang… - Frontiers in cell and …, 2022 - frontiersin.org
Breast cancer has become a leading cause of cancer-related deaths in women worldwide.
DNA methylation has been revealed to play an enormously important role in the …